Symptoms, risks, complications and palliative care in thoracic oncology

Thematic Poster
Chairs: R. Wiewrodt (Münster, Germany), D. Jovanovic (Beograd, Republic of Serbia), W. van Geffen (Leeuwarden, Netherlands)

Patient satisfaction and perception of indwelling pleural catheters S. Messeder (Aberdeen, United Kingdom), M. Thomson (Aberdeen, United Kingdom), G. Currie (Aberdeen, United Kingdom), M. Chetty (Aberdeen, United Kingdom)
Coping strategy influences quality of life in patients with advanced lung cancer A. Janssens (Edegem, Belgium), S. Derijcke (Kortrijk, Belgium), D. Galdermans (Antwerpen, Belgium), V. Surmont (Ghent, Belgium), E. De Droogh (Antwerpen, Belgium), A. Lefebure (Borgerhout, Belgium), E. Saenen (Reet, Belgium), E. Vandenbroucke (Antwerpen, Belgium), A. Morel (Bornem, Belgium), A. Sadowska (Bornem, Belgium), J. Van Meerbeeck (Edegem, Belgium)
Quality of life assessment in advanced stage of lung cancer patients before and after chemotherapy R. Niwas (New Delhi, India), J. Suri (New Delhi, India), S. Chakrabarti (New Delhi, India), M. Sen (New Delhi, India), R. Kumawat (New Delhi, India), G. Chawla (Jodhpur, India)
Psychosocial consequences of receiving a lung cancer diagnosis by telephone versus in an outpatient clinic. A pragmatic randomized trial. U. Bodtger (Næstved, Denmark), K. Marsaa (Copenhagen, Denmark), J. Brodersen (Copenhagen, Denmark), V. Siersma (Copenhagen, Denmark), C. Bang (Copenhagen, Denmark), A. Høegholm (Næstved, Denmark)
Correlation between Performance Status (PS) assessment between clinicians and oncologists in a United Kingdom (UK) District General Hospital (DGH) Lung cancer service A. Ali (Telford, United Kingdom), J. Ibrahim (Telford, United Kingdom), A. Mackintosh (Telford, United Kingdom), J. Olanrewaju (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom), A. Makan (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom), K. Srinivasan (Telford, United Kingdom), E. Crawford (Telford, United Kingdom)
The effect of nutritional indicators on prognosis of patients with advanced lung cancer G. Ak (Eskisehir, Turkey), S. Metintas (Eskisehir, Turkey), B. Gul (Istanbul, Turkey), F. Bogar (Eskisehir, Turkey), S. Yilmaz (Eskisehir, Turkey), M. Metintas (Eskisehir, Turkey)
Correlation of the independent Performance Status (PS) assessment of patients in a lung cancer clinic in a United Kingdom (UK) hospital between doctors, nurses and the patients’ self-assessment A. Ali (Telford, United Kingdom), J. Ibrahim (Telford, United Kingdom), K. Bhatia (Telford, United Kingdom), H. Thomason (Telford, United Kingdom), J. Mcadam (Telford, United Kingdom), A. Makan (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom), E. Crawford (Telford, United Kingdom), K. Srinivasan (Telford, United Kingdom)
Factors associated with altered quality of life among lung cancer patients (Preliminary study) B. Ben Bdira (Sousse, Tunisia), S. Aissa (Sousse, Tunisia), R. Houda (Sousse, Tunisia), W. Benzarti (Sousse, Tunisia), A. Knaz (Sousse, Tunisia), A. Hayouni (Sousse, Tunisia), A. Abdelghani (Sousse, Tunisia), A. Garrouch (Sousse, Tunisia), M. Benzarti (Sousse, Tunisia), I. Gargouri (Sousse, Tunisia)
Lent score and informed management decisions in malignant pleural effusions (MPE). When is little too much? G. Hardavella (Athens, Greece), M. Xigki (Athens, Greece), I. Karampinis (Athens, Greece), A. Tzonou (Athens, Greece), I. Kainis (Athens, Greece)
The Effect of Lipid Profile and Obesity on the Grade of Neutropenia in Patients with Small Cell Lung Cancer Treated with Etoposide-Cisplatin as First Regimen. T. Kim (Busan, Republic of Korea), H. Choi (Busan, Republic of Korea), J. Kim (Busan, Republic of Korea), H. Kim (Busan, Republic of Korea), C. Oak (Busan, Republic of Korea), T. Jang (Busan, Republic of Korea), M. Jung (Busan, Republic of Korea)
Treatment tolerance and survival in elderly patients with stage IV non-small cell lung cancer (NSCLC) R. Gijtenbeek (Leeuwarden, Netherlands), G. Helfrich (Rotterdam, Netherlands), B. Venmans (Leeuwarden, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands), K. De Jong (Leeuwarden, Netherlands), W. Van Geffen (Leeuwarden, Netherlands)
Comparison of risk prediction scores for venous thromboembolism in lung cancer patients: a retrospective cohort study H. Rouis (Ariana, Tunisia), H. Kamoun (Ariana, Tunisia), H. Rjeb (Ariana, Tunisia), A. Ben Tkhayat (Ariana, Tunisia), H. Smadhi (Ariana, Tunisia), H. Ben Abdelghaffar (Ariana, Tunisia), D. Greb (Ariana, Tunisia), I. Akrout (Ariana, Tunisia), H. Hassene (Ariana, Tunisia), L. Fekih (Ariana, Tunisia), M. Megdiche (Ariana, Tunisia)
Thromboembolic events in lung cancer patients treated with platinum-based chemotherapy H. Rouis (Ariana, Tunisia), H. Kamoun (Ariana, Tunisia), H. Rejeb (Ariana, Tunisia), A. Ben Tkhayat (Ariana, Tunisia), H. Smadhi (Ariana, Tunisia), D. Greb (Ariana, Tunisia), H. Ben Abdelghaffar (Ariana, Tunisia), I. Akrout (Ariana, Tunisia), H. Hassene (Ariana, Tunisia), L. Fekih (Ariana, Tunisia), M. Megdiche (Ariana, Tunisia)
Higher Age Puts Lung-Cancer Patients at Risk for Not Receiving Anti-cancer Treatment W. Choi (Daegu, Republic of Korea), C. Lee (Andong, Republic of Korea)
Two-stage treatment of non-small cell lung cancer (NSCLC) in patients with severe coronary heart disease. A. Reshetov (Saint-Petersburg, Russian Federation), G. Nikolaev (Saint-Petersburg, Russian Federation), A. Elkin (Saint-Petersburg, Russian Federation), S. Snepanov (Saint-Petersburg, Russian Federation), D. Ermakov (Saint-Petersburg, Russian Federation), V. Klimenko (Saint-Petersburg, Russian Federation)
Consequences of Lung Cancer: Mortality and Comorbidity in Danish Patients with Lung Cancer 1998-2010 A. Kirkeby (Horsens, Denmark), O. Hilberg (Vejle, Denmark), A. Løkke (Aarhus, Denmark)
Eosinophilia in lung cancer patients treated with immunotherapy A. Alves (Vila Nova de Gaia , Portugal), I. Sucena (Vila Nova de Gaia , Portugal), M. Dias (Vila Nova de Gaia , Portugal), D. Coutinho (Vila Nova de Gaia , Portugal), E. Silva (Vila Nova de Gaia , Portugal), T. Costa (Vila Nova de Gaia , Portugal), S. Conde (Vila Nova de Gaia , Portugal), A. Barroso (Vila Nova de Gaia , Portugal), S. Campainha (Vila Nova de Gaia , Portugal)
Predictors of immunotherapy induced immune-related adverse events M. Barata (Almada, Portugal), G. Santos (Almada, Portugal), H. Grumete (Almada, Portugal), M. Lopes (Almada, Portugal), D. Canário (Almada, Portugal), J. Duarte (Almada, Portugal)
Worse lung cancer outcome in patients with lower respiratory tract infection confirmed at the time of diagnosis A. Nagy (Budapest, Hungary), A. Kolonics-Farkas (Budapest, Hungary), N. Eszes (Budapest, Hungary), K. Vincze (Budapest, Hungary), V. Muller (Budapest, Hungary)
Upper limbs exercise capacity in high-risk patients undergoing lung resection J. Rodriguez Torres (Granada, Spain), F. Quero-Valenzuela (Granada, Spain), I. Piedra-Fernández (Granada, Spain), A. Heredia-Ciuró (Granada, Spain), L. López-López (Granada, Spain), M. Valenza (Granada, Spain)